Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed copies of the newspaper publication pertaining to the extract of the financial results of the Company for the quarter and year ended on 31st March 2023. The said extract of the financial results was published in The Echo of India (In English - All India edition) The Arthik Lipi in Bengali (Kolkata Edition) on 31st May 2023. This is for your information and records. This will also be hosted on Company's website at https:// www.shreeganeshbiotech.club /announcement/ Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 May 2023

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation …

BSE India

Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 31st March 2023, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 May 2023

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Regulations 30, 33 And Other Applicable Provisions Of …

BSE India

This is to inform you that Outcome of the Board Meeting of the Company held on Tuesday 30th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2023. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2023. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023 with unmodified opinion. The board meeting concluded on 05:00 P.M. Request you to kindly take on record the same. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 May 2023

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Outcome Of The Board …

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 May 2023

Annual Report

Annual report for Shree Ganesh Bio-Tech (India) Ltd. for FY-2023

None

pdf

Shree Ganesh Bio-Tech (India) Ltd.

23 May 2023

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 …

BSE India

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 30th May 2023 at registered office of the company inter alia, to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2023. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

17 May 2023

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

In compliance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please finds enclosed herewith Annual Secretarial Compliance Report of the Company for the financial year ended on 31st March, 2023 issued by secretarial auditor Mr. Haresh Kapuriya Practicing Company Secretaries. You are requested to take the same on your record. Thanking you.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

22 Apr 2023

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Submission Of Certificate Under Regulation 40(9) Of SEBI …

BSE India

With reference to the above, please find enclosed herewith Certificate under Regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 of the Company for the year ended 31.03.2023. Please find above and acknowledge the same. Thanking You.

pdf

Is Shree Ganesh Bio-Tech (India) Ltd. worth buying?

271 Votes:

Buy 73.8%

Sell 8.86%

Hold 17.34%